Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease

Author: Merims D.   Shabtai H.   Korczyn A. D.   Peretz C.   Weizman N.   Giladi N.  

Publisher: Springer Publishing Company

ISSN: 0300-9564

Source: Journal of Neural Transmission, Vol.111, Iss.10-11, 2004-10, pp. : 1447-1453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next